3BONNOMI A E, CELLA D F. A cross2cultural adaptation of the functional assessment of cancer therapy (FACT) quality of life measurementsystem for use in European oncology clinical trials [ J ~ . Qual Life News1, 1995, 12 (1):5-7.
4SILVEIRA AP, GONCALVES J, SEQUEIRA T, et al. Patient reportedoutcomes in head and neck cancer : selecting instrumentsfor quality of life integr-ation in clinical protocols [J]. Head Neck Oncol,2010,32(2) :32.
5BJORDAL K, HAMMERLID E,AHLNER ELMQVIST M, et al. Quality of life in head and neck cancer patients : validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire H&N35 [ J ]. J Clin Oncol, 1999,17(6) : 1008-1019.
6WEE J, TAN E H, TAI B C, et al. Randomized trial of radiotherapy vs concur- rent ehemo-radiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Vnion against stage 111 and IV nasoharyngeal cancer of the endemic variety [ J ]. J Clin Oncol, 2005,23 ( 27 ) : 6730-3738.
7HUANG P Y, CAO K J, GUO X, et al. A randomized trial of induction chemothe-rapy plus concurrent chemoradio-therapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma [ J]. Oral Oncol,2012,48(10) : 1038- 1044.
8LEE N, HARRIS J, GARDEN A S, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation the- rapy oneology group phase 11 trial 0225 [ J ]. J Clin Oneol, 2009,27 (22) : 3684- 3690.
